XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net loss $ (1,463,442) $ (6,261,398)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 5,397,498 6,274,321
Stock compensation 1,614,228 1,105,272
Bad debt expense 164,623 77,898
Gain on sale of real estate assets, net (2,487,528) (1,245,460)
Gain on extinguishment of government debt (10,000) (451,785)
Net change in fair value of marketable securities (39,429) 0
Impairment of real estate assets 608,000 1,730,851
Accretion of original issue discount 0 1,013,405
Amortization of financing costs 479,853 1,287,430
Amortization of above-market leases 42,064 50,682
Amortization of below-market leases (60,203) (170,887)
Straight-line rent adjustment (231,577) 108,998
Changes in operating assets and liabilities:    
Other assets 190,354 1,957,641
Accounts payable and accrued liabilities (1,221,725) (1,344,636)
Accrued real estate taxes (607,773) (438,915)
Net cash provided by operating activities 2,374,943 3,693,417
Cash flows from investing activities:    
Real estate acquisitions (22,224,826) (10,161,613)
Additions to buildings and tenant improvements (1,597,186) (2,834,373)
Investment in marketable securities (3,819,882) 0
Proceeds from sale of marketable securities 2,380,476 0
Additions to deferred leasing costs (117,062) (175,828)
Proceeds from sales of real estate, net 49,583,445 40,849,654
Net cash provided by investing activities 24,204,965 27,677,840
Cash flows from financing activities:    
Proceeds from mortgage notes payable, net of issuance costs 11,703,440 14,152,838
Proceeds from government debt relief 0 451,785
Repayment of mortgage notes payable (43,069,312) (36,808,331)
Repayment of note payable (7,675,598) (6,324,401)
Payment of extension costs, note payable 0 (351,025)
Payment of deferred offering costs (572,458) (45,016)
Distributions to noncontrolling interests, net (7,588,197) (2,366,009)
Issuance of stock for Initial Public Offering, net of underwriters fees 0 2,050,000
Issuance of Common Stock Series A and warrants, net of offering costs 8,871,879 0
Issuance of Preferred Stock Series D, net of offering costs 20,489,803 0
Repurchase of common stock (110,631) (18,000)
Dividends paid to Series D preferred stockholders (994,263) 0
Dividends paid to Series A common stockholders (4,473,399) (963,456)
Net cash used in financing activities (23,418,736) (30,221,615)
Net increase in cash equivalents and restricted cash 3,161,172 1,149,642
Cash, cash equivalents and restricted cash - beginning of period 11,540,917 10,391,275
Cash, cash equivalents and restricted cash - end of period 14,702,089 11,540,917
Supplemental disclosure of cash flow information:    
Interest paid-mortgage notes payable 4,320,174 5,892,025
Interest paid-notes payable 103,861 778,414
Unpaid deferred financing costs 15,449 83,659
Non-cash financing activities:    
Issuance of stock for limited partnership interests 0 1,247,990
Dividends payable - Preferred Stock Series D $ 179,685 $ 0